Skip to main content
. 2024 Jan 19;105(3):166–174. doi: 10.1159/000535672

Table 3.

ANCOVA results for FD symptoms with regard to improvements with STW 5-II versus placebo after 28 days

GIS item MD (95% CI) p value
Epigastric pain 0.39 (0.32–0.55) <0.0001*
Fullness 0.38 (0.20–0.56) <0.0001*
Early satiety 0.36 (0.17–0.55) 0.0002*
Nausea 0.28 (0.08–0.47) 0.0071*
Vomiting 0.06 (−0.25 to 0.37) 0.6950
Abdominal cramps 0.32 (0.14–0.50) 0.0005*
Acid eructation/heartburn 0.45 (0.25–0.65) <0.0001*
Sickness 0.27 (0.08–0.46) 0.0052*
Loss of appetite 0.33 (0.13–0.54) 0.0018*
Retrosternal discomfort 0.52 (0.32–0.71) <0.0001*
Sum score 2.44 (1.57–3.3) <0.0001*

CI, confidence interval; GIS, gastrointestinal symptom.